Erythropoietin & ESRD payments: a promising policy outcome?
Roe
W
W
D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000628:therapy; D006278:Medicare / Q000191:economics; D011994:Recombinant Proteins / Q000627:therapeutic use; D012051:Reimbursement Mechanisms / Q000191:economics*; D006435:Renal Dialysis / Q000191:economics; D014481:United States
D011994:Recombinant Proteins; D004921:Erythropoietin